Teleflex to Present at the 9th Annual SVB Leerink Global Healthcare Conference

NEXT STORY
The Global In-Vitro Diagnostics market is expected to reach US$ 107,658.83 Mn in 2027 from US$ 68,608.16 Mn in 2019
PREV STORY
Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of ATRC-101 in Patients with Select Solid Tumors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ObsEva SA Announces Initiation of Phase 3 IMPLANT 4 Trial of Nolasiban in Europe, Canada and Russia for Improving IVF Outcomes

Geneva, Switzerland and Boston, MA – November 28, 2018 – ObsEva SA (NASDAQ: OBSV ...

author_avatar
NASDAQ Market News

DEINOVE strengthens its Business Development activity with the arrival of Sébastien Enault

Sébastien Enault brings to the Company a proven track record in the development of ...

author_avatar
NASDAQ Market News

 Asterias Provides Update for its AST-OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury

- Results to Date Show AST-OPC1’s Favorable Safety Profile, Potential for Cell Engraftment and ...

author_avatar
NASDAQ Market News